Literature DB >> 7718250

Determination of cause of death among breast cancer cases in the Swedish randomized mammography screening trials. A comparison between official statistics and validation by an endpoint committee.

L Nyström1, L G Larsson, L E Rutqvist, A Lindgren, M Lindqvist, S Rydén, I Andersson, N Bjurstam, G Fagerberg, J Frisell.   

Abstract

Between 1976 and 1982, four randomized mammography screening trials started in five screening centres in Sweden, involving 282,777 women (156,911 invited and 125,866 controls) with the aim to study if invitation to screening reduced the breast cancer mortality. An overview of the trials was performed to reduce the confidence intervals for the relative risk estimates. All 1,296 deaths occurring in women with breast cancer detected after randomization were evaluated by an independent endpoint committee (EPC), consisting of four physicians who reviewed collected medical information that was blinded regarding mammography screening. If there was disagreement between the EPC members at the initial individual evaluation the final classification was made at consensus meetings. In only 6.9% (n = 89) of the cases was there disagreement as to whether breast cancer was or was not the underlying cause of death. It was also found that 'breast cancer as underlying cause of death' and 'breast cancer as underlying or contributory cause of death' according to Statistics Sweden resulted in relative risk estimates very similar to those based on the classification by the EPC. The study thus supports the use of official health statistics in the evaluation of randomized breast screening trials in Sweden.

Entities:  

Mesh:

Year:  1995        PMID: 7718250     DOI: 10.3109/02841869509093948

Source DB:  PubMed          Journal:  Acta Oncol        ISSN: 0284-186X            Impact factor:   4.089


  17 in total

1.  The Swedish randomised controlled trial on mammography screening has been properly designed, conducted and analysed.

Authors:  Lennarth Nyström
Journal:  J R Soc Med       Date:  2015-11       Impact factor: 5.344

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Predictive value of the time-intensity curves on dynamic contrast-enhanced magnetic resonance imaging for lymphatic spreading in breast cancer.

Authors:  Shuhei Komatsu; Chol Joo Lee; Daisuke Ichikawa; Takashi Hamashima; Noriaki Morofuji; Koichi Shirono; Yohei Hosokawa; Harumi Okabe; Hideaki Kurioka; Hisakazu Yamagishi; Takahiro Oka
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

4.  Mammographic density reduction is a prognostic marker of response to adjuvant tamoxifen therapy in postmenopausal patients with breast cancer.

Authors:  Jingmei Li; Keith Humphreys; Louise Eriksson; Gustaf Edgren; Kamila Czene; Per Hall
Journal:  J Clin Oncol       Date:  2013-04-22       Impact factor: 44.544

5.  Menopausal hormone therapy in relation to breast cancer characteristics and prognosis: a cohort study.

Authors:  Lena U Rosenberg; Fredrik Granath; Paul W Dickman; Kristjana Einarsdóttir; Sara Wedrén; Ingemar Persson; Per Hall
Journal:  Breast Cancer Res       Date:  2008-09-19       Impact factor: 6.466

6.  Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database.

Authors:  Philippe Autier; Mathieu Boniol; Carlo La Vecchia; Carlo LaVecchia; Lars Vatten; Anna Gavin; Clarisse Héry; Mary Heanue
Journal:  BMJ       Date:  2010-08-11

7.  Partitioning of excess mortality in population-based cancer patient survival studies using flexible parametric survival models.

Authors:  Sandra Eloranta; Paul C Lambert; Therese M L Andersson; Kamila Czene; Per Hall; Magnus Björkholm; Paul W Dickman
Journal:  BMC Med Res Methodol       Date:  2012-06-24       Impact factor: 4.615

8.  Common genetic variability in ESR1 and EGF in relation to endometrial cancer risk and survival.

Authors:  K Einarsdóttir; H Darabi; K Czene; Y Li; Y L Low; Y Q Li; C Bonnard; S Wedrén; E T Liu; P Hall; J Liu; K Humphreys
Journal:  Br J Cancer       Date:  2009-03-24       Impact factor: 7.640

9.  Excess mortality in women of reproductive age from low-income countries: a Swedish national register study.

Authors:  Annika Esscher; Bengt Haglund; Ulf Högberg; Birgitta Essén
Journal:  Eur J Public Health       Date:  2012-07-31       Impact factor: 3.367

10.  The influence of menstrual risk factors on tumor characteristics and survival in postmenopausal breast cancer.

Authors:  Chantal C Orgéas; Per Hall; Lena U Rosenberg; Kamila Czene
Journal:  Breast Cancer Res       Date:  2008-12-16       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.